Menostar FDA Approval History
FDA Approved: Yes (First approved June 8, 2004)
Brand name: Menostar
Generic name: estradiol transdermal system
Treatment for: Prevention of Osteoporosis
Menostar (estradiol transdermal system) is an estrogen patch for the prevention of postmenopausal osteoporosis.
Development Timeline for Menostar
|Jun 8, 2004||Menostar Berlex - Treatment for Osteoporosis Prevention|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.